HGS-ETR2 to Treat Children With Solid Tumors
This study has been terminated.
National Cancer Institute (NCI)
Information provided by:
National Institutes of Health Clinical Center (CC)
First received: January 25, 2007
Last updated: January 24, 2017
Last verified: October 9, 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||October 9, 2015|
|Primary Completion Date:||April 28, 2011 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL. Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors. J Clin Oncol. 2012 Nov 20;30(33):4141-7. doi: 10.1200/JCO.2012.44.1055.